...
首页> 外文期刊>The Journal of Steroid Biochemistry and Molecular Biology >Epigenetic regulation of the 1,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1) in colon cancer cells.
【24h】

Epigenetic regulation of the 1,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1) in colon cancer cells.

机译:1,25-二羟基维生素D3 24-羟化酶(CYP24A1)在结肠癌细胞中的表观遗传学调控。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Calcitriol is the hormonally active form of vitamin D and has anti-proliferative and pro-apoptotic effects. Calcitriol and its precursor calcidiol (25(OH)D3) are degraded by the 1,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1). This enzyme is overexpressed in colorectal tumors, however, the mechanisms of this overexpression remain to be elucidated. CYP24A1 mRNA level differs among colorectal cancer cell lines and range from almost undetectable to high. Since DNA methylation and histone acetylation regulate CYP24A1 gene expression in prostate cancer cell lines, we investigated whether epigenetic mechanisms could explain the differences in basal expression of CYP24A1 in colon cancer cells. Methyltransferase inhibitor 5-aza-2'-deoxycytidine (DAC) treatment resulted in an over 50-fold induction of CYP24A1 mRNA expression in Coga1A and HT-29 cells but in no response in Caco2/AQ and Coga13 cells. This finding is supported by a strong increase in CYP24A1 activity after DAC treatment in Coga1A (35%). In addition, calcitriol and DAC had synergistic effects on CYP24A1 gene transcription. Interestingly, the CYP24A1 promoter was not methylated in Coga1A and HT-29 (<5%), while in Caco2/AQ it was 62% methylated. This suggests that DNA demethylation must activate genes upstream of CYP24A1 rather than act on the gene itself. However, transcriptional regulators of CYP24A1 such as vitamin D receptor (VDR), retinoid X receptor (RXR), specificity protein 1 (SP1), or mediator complex subunit 1 (MED1) were not upregulated. We conclude that in colon cancer cells, CYP24A1 gene expression is inducible by methyltransferase and some histone deacetylase inhibitors in a cell line-dependent manner. This effect does not correlate with the methylation state of the promoter and therefore must affect genes upstream of CYP24A1. This article is part of a Special Issue 'Vitamin D Workshop'.
机译:骨化三醇是维生素D的激素活性形式,具有抗增殖和促凋亡作用。骨化三醇及其前体骨化二醇(25(OH)D3)被1,25-二羟基维生素D3 24-羟化酶(CYP24A1)降解。该酶在结直肠肿瘤中过表达,但是,这种过表达的机制仍有待阐明。 CYP24A1 mRNA水平在大肠癌细胞系之间有所不同,范围从几乎无法检测到很高。由于DNA甲基化和组蛋白乙酰化调节CYP24A1基因在前列腺癌细胞系中的表达,我们研究了表观遗传机制是否可以解释CYP24A1在结肠癌细胞中基础表达的差异。甲基转移酶抑制剂5-氮杂2'-脱氧胞苷(DAC)处理导致Coga1A和HT-29细胞中CYP24A1 mRNA表达的诱导超过50倍,但Caco2 / AQ和Coga13细胞中无反应。 CYP24A1活性在Coga1A中经过DAC处理后显着增加(35%),从而支持了这一发现。此外,骨化三醇和DAC对CYP24A1基因的转录有协同作用。有趣的是,CYP24A1启动子在Coga1A和HT-29中未甲基化(<5%),而在Caco2 / AQ中却被62%甲基化。这表明DNA去甲基化必须激活CYP24A1上游的基因,而不是对基因本身起作用。但是,CYP24A1的转录调节剂如维生素D受体(VDR),类维生素A X受体(RXR),特异性蛋白1(SP1)或介体复合物亚基1(MED1)并未上调。我们得出的结论是,在结肠癌细胞中,CYP24A1基因表达可通过甲基转移酶和某些组蛋白脱乙酰基酶抑制剂以细胞系依赖性方式诱导。该作用与启动子的甲基化状态无关,因此必须影响CYP24A1上游的基因。本文是“维生素D研讨会”特刊的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号